Key considerations during the transition from the acute phase of the COVID-19 pandemic: a narrative review

P Rzymski, M Pokorska-Śpiewak, T Jackowska… - Vaccines, 2023 - mdpi.com
The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …

mRNA vaccines against respiratory viruses

JA Whitaker, HM El Sahly… - Current Opinion in …, 2023 - journals.lww.com
mRNA vaccines against respiratory viruses : Current Opinion in Infectious Diseases mRNA
vaccines against respiratory viruses : Current Opinion in Infectious Diseases Log in or Register …

Evaluation of waning of SARS-CoV-2 vaccine–induced immunity: a systematic review and meta-analysis

F Menegale, M Manica, A Zardini, G Guzzetta… - JAMA Network …, 2023 - jamanetwork.com
Importance Estimates of the rate of waning of vaccine effectiveness (VE) against COVID-19
are key to assess population levels of protection and future needs for booster doses to face …

Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective …

MMI Meslé, J Brown, P Mook, MA Katz… - The Lancet …, 2024 - thelancet.com
Summary Background By March, 2023, 54 countries, areas, and territories (hereafter CAT) in
the WHO European Region had reported more than 2· 2 million COVID-19-related deaths to …

[HTML][HTML] Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian …

L Moscara, V Venerito, A Martinelli, A Di Lorenzo… - Vaccine, 2023 - Elsevier
Abstract In October/December 2021, World Health Organization and other international
agencies recommended the offer of the third dose of anti-SARS-CoV-2 vaccine. In this …

Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2

M Giovanetti, F Branda, E Cella… - Journal of Medical …, 2023 - Wiley Online Library
This comprehensive review focuses on the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) and its impact as the cause of the COVID‐19 pandemic. Its objective is to …

Opportunities and challenges for T cell-based influenza vaccines

TR Mosmann, AJ McMichael, A LeVert… - Nature Reviews …, 2024 - nature.com
Vaccination remains our main defence against influenza, which causes substantial annual
mortality and poses a serious pandemic threat. Influenza virus evades immunity by rapidly …

Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study

B Liu, S Stepien, T Dobbins, H Gidding… - The Lancet Regional …, 2023 - thelancet.com
Background Few studies have examined effectiveness of COVID-19 vaccines against
COVID-19 and all-cause mortality across different pandemic periods in 2022. Methods We …

Understanding low COVID-19 booster uptake among US adults

ET Jacobs, FM Cordova-Marks, LV Farland, KC Ernst… - Vaccine, 2023 - Elsevier
Abstract Background Vaccinations against SARS-CoV-2 have consistently been shown to
reduce the risk of severe COVID-19 disease. However, uptake of boosters has stalled in the …

Comparing role of religion in perception of the COVID-19 vaccines in Africa and Asia Pacific

S Jin, AR Cook, R Kanwagi, HJ Larson… - Communications medicine, 2024 - nature.com
Background In the midst of the global COVID-19 vaccine distribution challenge, religion
stands out as a key determinant of vaccine hesitancy and health choices. Notably, the …